Latest News

November 21, 2019
Quality of life and 6-minute walk test also improve with this treatment combination.
 
November 21, 2019
The link between prolonged opioid treatment and an increased frequency, severity of migraines has been attributed to the discovery of a peptide confirmed in mice that distinguishes the relationship of migraine pain and opioid-induced hyperalgesia (OIH), according to study findings.
November 21, 2019
For both in-network access and provider reimbursement rates, disparities between physical and behavioral healthcare is worsening for American families seeking affordable and available mental healthcare and addiction treatment, according to study findings.
November 21, 2019
BE READY is designed to evaluate the safety and efficacy of bimekizumab, humanized monoclonal IgG1 antibody that targets and neutralizes interleukin- (IL-)17A and IL-17F, a pair of cytokines that propel the inflammatory process through their effects on other messengers in the body that trigger chronic inflammatory response.
November 21, 2019
Regardless of the government's removal of cost and access obstacles to flu vaccinations, adherence remains stagnant; multistate hepatitis A outbreak linked to blackberries sold in grocery store chain; President Trump's FDA nominee Stephen Hahn avoids talk on the suspended e-cig flavor ban during his Senate confirmation hearing. 
November 20, 2019
Researchers discovered new molecular drivers of Parkinson disease (PD) and determined their impact on the functions of genes involved in PD, potentially leading to novel treatments, according to study findings.
November 20, 2019
The FDA has approved a new treatment for adult patients with acute hepatic porphyria (AHP) a rare genetic disorder. Givlaari is an RNA interference therapeutic targeting aminolevulinic acid synthase 1. Simultaneously, Alnylam Pharmaceuticals announced a new framework for value-based agreements to help patients gain access to the treatment.
November 20, 2019
As part of its Quality Improvement Snapshots series, TMF Health Quality Institute issued 4 healthcare quality improvement efforts, highlighting the use of a rescue pack for patients with chronic obstructive pulmonary disease (COPD) as an impactful strategy in managing COPD-related exacerbations.
November 20, 2019
Under the ACA, patients with HIV in Medicaid expansion states have greater access to care.
November 20, 2019
A House committee approves a bill to ban all flavored tobacco products; anal cancer rates are on the rise; the debate continues over competing healthcare measures.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.